In the last trading session, 1.49 million shares of the Guardant Health Inc (NASDAQ:GH) were traded, and its beta was 1.49. Most recently the company’s share price was $43.60, and it changed around -$0.8 or -1.80% from the last close, which brings the market valuation of the company to $5.39B. GH currently trades at a discount to its 52-week high of $50.89, offering almost -16.72% off that amount. The share price’s 52-week low was $15.81, which indicates that the current value has risen by an impressive 63.74% since then. We note from Guardant Health Inc’s average daily trading volume that its 10-day average is 2.38 million shares, with the 3-month average coming to 2.07 million.
Guardant Health Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.44. If we narrow it down even further, the data shows that 0 out of 23 analysts rate the stock as a Sell; another 7 rate it as Overweight. Among the rest, 2 recommended GH as a Hold, whereas 14 deemed it a Buy, and 0 rated it as Underweight. Guardant Health Inc is expected to report earnings per share of -0.5 for the current quarter.
Guardant Health Inc (NASDAQ:GH) trade information
Instantly GH has showed a red trend with a performance of -1.80% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 48.58 on recent trading dayincreased the stock’s daily price by 10.25%. The company’s shares are currently up 42.72% year-to-date, but still down -7.57% over the last five days. On the other hand, Guardant Health Inc (NASDAQ:GH) is 18.78% up in the 30-day period. We can see from the shorts that 5.77 million shares have been sold at a short interest cover period of 2.26 day(s).
The consensus price target as assigned by Wall Street analysts is $40, which translates to bulls needing to decrease their stock price by -9.0% from its current value. Analyst projections state that GH is forecast to be at a low of $40 and a high of $40.
Guardant Health Inc (GH) estimates and forecasts
The year-over-year growth rate is expected to be 29.28%, up from the previous year.
Consensus estimates provided by 18 financial analysts predict the company will bring in an average of 192.5M in revenue for the current quarter. 17 analysts expect Guardant Health Inc to make 190.4M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 155.05M and 168.49M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 24.15%. Forecasts for the next quarter put sales growth at 13.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -8.88%. Guardant Health Inc earnings are expected to increase by 20.26% in 2025, but the outlook is positive 16.87% per year for the next five years.
GH Dividends
Guardant Health Inc’s next quarterly earnings report is expected to be released in March.
Guardant Health Inc (NASDAQ:GH)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 4.74% of Guardant Health Inc shares, and 104.70% of them are in the hands of institutional investors. The stock currently has a share float of 109.91%. Guardant Health Inc stock is held by 391.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 9.5609% of the shares, which is about 11.64 million shares worth $336.07 million.
BLACKROCK INC., with 9.2332% or 11.24 million shares worth $324.55 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Specialized-Health Care Fund and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Oct 31, 2024. The former held 8.33 shares worth $363.19 million, making up 6.74% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 3.67 shares worth around $159.84 million, which represents about 2.97% of the total shares outstanding.
